ABOUT US OUR PRODUCTS DISTRIBUTORS TECHNOLOGY INVESTORS NEWS CENTER The Diaxonhit group, resulting from the acquisition of InGen BioSciences by Exonhit, is a French fully integrated leader in the field of in-vitro diagnostic with expertise ranging from discovery to the commercialization of specialty diagnostic products. Contact us Press Releases see all news May 25, 2016 - DIAXONHIT and the University Hospitals of Strasbourg launch the Central... March 24, 2016 - DIAXONHIT - Group 2015 annual results Congresses And Events MEDICA Düsseldorf 14-17 November 2016 Your browser does not support the video tag or the file format of this video. Allomap central labo inauguration Site map - © 2016 Diaxonhit. All Rights Reserved - Legal information -